Lee, Ji Hyun
(Division of Advanced Analysis, National Institute of Food and Drug Safety Evaluation, Ministry of Food & Drug Safety, Osong Health Technology Administration Complex)
Choi, Ji Yeon (Division of Advanced Analysis, National Institute of Food and Drug Safety Evaluation, Ministry of Food & Drug Safety, Osong Health Technology Administration Complex) Park, Hanna (Division of Advanced Analysis, National Institute of Food and Drug Safety Evaluation, Ministry of Food & Drug Safety, Osong Health Technology Administration Complex) Min, Ah Young (Division of Advanced Analysis, National Institute of Food and Drug Safety Evaluation, Ministry of Food & Drug Safety, Osong Health Technology Administration Complex) Kim, Nam Sook (Division of Advanced Analysis, National Institute of Food and Drug Safety Evaluation, Ministry of Food & Drug Safety, Osong Health Technology Administration Complex) Park, Seong Soo (Division of Advanced Analysis, National Institute of Food and Drug Safety Evaluation, Ministry of Food & Drug Safety, Osong Health Technology Administration Complex) Park, Sung-Kwan (Division of Advanced Analysis, National Institute of Food and Drug Safety Evaluation, Ministry of Food & Drug Safety, Osong Health Technology Administration Complex) Kang, Ho-il (Division of Advanced Analysis, National Institute of Food and Drug Safety Evaluation, Ministry of Food & Drug Safety, Osong Health Technology Administration Complex) |
1 | L. J. Greenfield, S. H. Zaman, M. L. Sutherland, S. C. Lummis, M. I. Niemeyer, E. A. Barnard, and R. L. Macdonald, Neuropharmacology, 42, 502-521 (2002). DOI |
2 | C. Gottesmann, Neuroscience, 111, 231-239 (2002). DOI |
3 | J. Wang, B. Chen, and S. Yao, Food addit. Contam., 25, 822-830 (2008). DOI |
4 | Z. Wang, J. Zhang, and Y. Zhang, J. Chin. Mass Spec. Soc., 30, 282-286 (2009). |
5 | A. Yan, X. Li, C. Xi, L. Zhang, S. Xia, G. Wang, B. Tang, and Z. Mu, Chinese J. Anal. Chem., 41, 509-516 (2013). DOI |
6 | E. Deconinck, P. Y. Sacre, P. Courselle, and J. O. De Beer, J. Chromatogr. Sci., 51, 791-806 (2013). DOI |
7 | AOAC Official Methods of Analysis. Internationalconference on harmonization of harmonized tripartiteguideline, validation of analytical procedures: text andmethodology. |
8 | AOAC International, Rockville, MD (2005). |
9 | ICH International conference on Harmonization. Harmonized tripartite guideline, validation of analyticalprocedures: text and methodology Q2 |
10 | (R1). European Medicines Agency (EUMA), London, UK . |
11 | A, El-Gindy, Il Farmaco, 60, 745 (2005). DOI |
12 | R. A. Menck, D. S. De Lima, S. C. Seulin, V. Leyton, C. A. Pasqualucci, D. R. Munoz, M. D. Osseltore, M. Yonamine, J. Sep. Sci., 35, 3361-3368 (2012). DOI |
13 | X. Zhang, Z. Lin, J. Li, Z. Huang, Y. Rao, H. Liang, J. Yan, and F. Zheng. Drug Testing and Analysis, 9, 588-595 (2017). DOI |
14 | Q. Gao, B. Che, Z. Zhang, H. Dai, and H. Guo, J. Chin. Pharm. Univ., 39, 142-146 (2008). DOI |
15 | B. Zhu, Z. Zhao, Z. Wang, Q. Xue, and L. Zhao, Chin. J. Pharm. Anal., 30, 745-751 (2010). |
16 | J. Liu, L. Xiao, X. Guan, Y. Xiong, T. Wang, and J. Li, Chin. J. Pharm. Anal., 31, 376-379 (2011). |
17 | P. Jin, Z. Wang, W. Wang, D. Zou, J. Ma, and X. Hu, Chin Pharm. J., 47, 462-466 (2012). |